The Src-PI3K-Akt and apoptosis signaling pathway-targeted therapy with novel pro-apoptotic FUS1-nanoparticles and Src kinase inhibitors for lung cancer

被引:0
|
作者
Wu, Guanglin
Sakai, Ryo
Xu, Kai
Hangauer, David
Roth, Jack
Ji, Lin
机构
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] SUNY Buffalo, Buffalo, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2823
引用
收藏
页数:1
相关论文
共 23 条
  • [1] The Src-PI3K-Akt and apoptosis signaling pathway-targeted therapy with novel pro-apoptotic FUS1-nanoparticles and Src kinase inhibitors for lung cancer
    Ji Lin
    Wu Guanglin
    Sakai, Ryo
    Roth, Jack A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S601 - S601
  • [2] THE PDGFR/SRC SIGNALING PATHWAY-TARGETED THERAPY WITH NOVEL TUSC2-NANOPARTICLES AND TYROSINE KINASE INHIBITORS FOR HUMAN LUNG CANCER
    Wu, Quanglin
    Liu, Qing
    Sakai, Ryo
    Hangauer, David
    Roth, Jack
    Ji, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S459 - S459
  • [3] ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway
    Luo, Juan
    Zeng, Beilei
    Tao, Chunfang
    Lu, Mengqi
    Ren, Guosheng
    PEERJ, 2020, 8
  • [4] Overcoming gefitinib resistance in NSCLC via inactivation of the PI3K/AKT signaling pathway by a combination of FUS1 nanoparticles and EGFR inhibitors.
    Kawashima, Hiroyuki
    Jayachandran, Gitanjali
    Deng, Wuguo
    Xu, Kai
    Minna, John D.
    Roth, Jack A.
    Ji, Lin
    CANCER RESEARCH, 2006, 66 (08)
  • [5] Src-Met signaling confers apoptosis resistance to EGFR and PI3K co-targeting independently of AKT and ERK pathway activation in head and neck cancer
    Anisuzzaman, Abu S.
    Haque, Abedul
    Chen, Zhuo G.
    Shin, Dong M.
    Amin, A. R. M. Ruhul
    CANCER RESEARCH, 2020, 80 (16)
  • [6] A novel evodiamine amino derivative as a PI3K/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells
    Wang, Tingting
    Qi, Di
    Hu, Xueyuan
    Li, Na
    Zhang, Xue
    Liu, Hongming
    Zhong, Cailing
    Zhang, Jingqing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906
  • [7] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells
    Tang, Chunlan
    Luo, Hu
    Luo, Dan
    Yang, Heping
    Zhou, Xiangdong
    ONCOLOGY REPORTS, 2018, 39 (02) : 611 - 618
  • [8] Mechanistic insights into Retama raetam's anti-proliferative and pro-apoptotic effects in A549 lung cancer cells: targeting PI3K/Akt pathway and ROS production
    Alshehri, Mohammed Ali
    Seyed, Mohamed Ali
    Panneerselvam, Chellasamy
    Sayed, Samy M.
    Shukry, Mustafa
    TOXICOLOGY RESEARCH, 2024, 13 (05)
  • [9] Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways
    Xie, Chen Qiong
    Zhou, Ping
    Zuo, Jian
    Li, Xiang
    Chen, Yong
    Chen, Jian Wei
    ONCOLOGY LETTERS, 2016, 12 (05) : 3586 - 3590
  • [10] Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer
    Zhang, Lingling
    Gong, Yanju
    Zhang, Lei
    Liang, Bing
    Xu, Huan
    Hu, Wangming
    Jin, Zhong
    Wu, Xiao
    Chen, Xiongbin
    Li, Min
    Shi, Liangqin
    Shi, Yaping
    Li, Mingjian
    Huang, Yong
    Wang, Yong
    Yang, Lan
    FRONTIERS IN ONCOLOGY, 2022, 12